Potential drug–drug interactions in COVID 19 patients in treatment with lopinavir/ritonavir()

OBJECTIVES: To determine the prevalence of potential interactions in COVID19 patients receiving lopinavir/ritonavir (LPV/r). The secondary objective was to develop recommendations and identify the risk factors associated with presenting potential interactions with LPV/r. SUBJECTS AND METHODS: Cross-...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandariz-Nuñez, David, Correas-Sanahuja, Marcelo, Guarc, Eva, Picón, Rafael, García, Bárbara, Gil, Rocío
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486822/
https://www.ncbi.nlm.nih.gov/pubmed/32953990
http://dx.doi.org/10.1016/j.medcle.2020.06.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486822/
https://www.ncbi.nlm.nih.gov/pubmed/32953990
http://dx.doi.org/10.1016/j.medcle.2020.06.012

Ejemplares similares